Development of a research agenda for endovascular treatment of venous thromboembolism: Proceedings from a multidisciplinary consensus panel

Journal of Vascular and Interventional Radiology

Volumn 16, Issue 12, 2005, Pages 1567-1573

  Vedantham, Suresh ^a   Rundback, John H ^b   Comerota, Anthony J ^d   Hunter, David W ^e   Meissner, Mark H ^g   Hofmann, Lawrence V ⁱ   Horne, McDonald ^j   Gloviczki, Peter ^f   Andrews, R Torrance ^h   Fan, Chieh Min ^k   Hume, Keith M ^m   Goldhaber, Samuel K ^l   Tapson, Victor F ⁿ   Razavi, Mahmood K ^o   Min, Robert J ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Orthopaedic Surgery   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d JOBST VASCULAR CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ JOHNS HOPKINS HOSPITAL   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l BRIGHAM AND WOMEN S HOSPITAL   (United States)

^m Society of Interventional Radiology   (United States)

ⁿ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^o ST JOSEPH HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL RESEARCH; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; ENDOVASCULAR SURGERY; HUMAN; INTERVENTIONAL RADIOLOGY; MEDICAL RESEARCH; MINIMALLY INVASIVE SURGERY; OUTCOMES RESEARCH; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM; FIBRINOLYTIC THERAPY; METHODOLOGY; THROMBECTOMY; VEIN THROMBOSIS;

BIOMEDICAL RESEARCH; HUMANS; THROMBECTOMY; THROMBOLYTIC THERAPY; VENOUS THROMBOSIS;

EID: 33744768075     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000183868.45154.57     Document Type: Conference Paper

References (32)

1. Lawrence PF, Gazak CE. Epidemiology of chronic venous insufficiency. In: Ballard, JL, Bergan JJ, eds. Chronic venous insufficiency: diagnosis and treatment. London: Springer-Verlag, 2000; 3-8.
2. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part I. Epidemiology, pathophysiology, and diagnosis. Circulation 2003; 198:2726-2729.
3. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191:487-494.
4. Fava M, Loyola S. Applications of percutaneous mechanical thrombectomy in pulmonary embolism. Tech Vasc Interv Radiol 2003; 6:53-58.
5. Rundback JH, Dorfman G, Safriel Y, et al. Development of a research agenda for interventional oncology: proceedings from an interdisciplinary consensus panel. J Vasc Interv Radiol 2004; 15:7-12.
6. Rundback JH, Wright K, McLennan G, et al. Current status of interventional radiology research: results of a CIRREF survey and implications for future research strategies. J Vasc Interv Radiol 2003; 14:1103-1110.
7. Mewissen WM, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211:39-49.
8. Rutherford RB, Padberg FT, Comerota AJ, et al. Venous outcomes assessment. In: Gloviczki P, Yao JST, eds. Handbook of venous disorders, 2nd edition: guidelines of the American Venous Forum. London: Arnold, 2001;497-508.
9. Lamping DL, Abenhaim L, Kurz X, et al. Measuring quality of life and symptoms in chronic venous disorders of the leg: development and psychometric evaluation of the VEINES-QOL/VEINES-SYM questionnaire. Qual Life Res 1998; 7:621-622.
10. Kahn SR, M'lan CE, Lamping DL, et al, VEINES Study Group. Relationship between clinical classification of chronic venous disease and patient-reported quality of life: results from an international cohort study. J Vasc Surg 2004; 39:823-828.
11. Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004; 239:118-126.
12. Strandness JE Jr, Langlois Y, Cramer M, et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250:1289-1292.
13. Stanley JC, Barnes RW, Ernst CB. Vascular surgery in the United States: workforce issues. J Vasc Surg 1996; 23:172-181.
14. Gonsalves CF. Venous leg ulcers. Tech Vasc Interv Radiol 2003; 6:132-136.
15. Bosanquet N. Costs of venous ulcers: from maintenance therapy to investment programmes. Phlebology Suppl 1992; 1:44-46.
16. O'Donnell TF Browse, NL, Burnand KG, Thomas ML. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977; 22 (5):483-488.
17. Bartolo M. Socioeconomic impact of venous diseases in Italy. Phlebologie 1992; 45:423-431.
18. Goldhaber SZ. Deep-vein thrombosis: advancing awareness to protect patient lives. White paper - Public Health Leadership Conference on Deep-Vein Thrombosis. Washington, DC: American Public Health Association, 2003.
19. National Quality Forum, Joint Commission on Accreditation of Healthcare Organizations. National consensus standards for the prevention and care of deep vein thrombosis: call for steering committee nominations and technical advisory panel nominations. Available at: www.qualityforum.org/txDVTSCTAPcallfinal12.17. 04.pdf. Accessed: . Amy Lindsay in Secrets of a Chambermaid 1
20. Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand 1982; 211:65-68.
21. Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis in an interim report of a prospective trial. Br J Surg 1979; 66:838-843.
22. Goldhaber SZ, Buring JE, Lipnick RJ, et al. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76:393-397.
23. Plate G, Eklof B, Norgren L, et al. Venous thrombectomy for iliofemoral venous thrombosis-10-year results of a prospective randomized study. Eur J Vasc Endovasc Surg 1997; 14:333-343.
24. Comerota AJ, Throm RC, Mathias SD, et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000; 32:130-137.
25. AbuRahma AF, Perkins SE, Wulu JT, et al. Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001; 233:752-760.
26. Elsharawy M, Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis: a randomised clinical trial. Eur J Vasc Endovasc Surg 2002; 24:209-214.
27. Vedantham S, Khilnani N, Min R. Deep-vein thrombosis [letter]. N Engl J Med 2004; 351:2133-2134.
28. Buller HR, Hull RD, Hyers TM, et al. Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(suppl):401S-428S.
29. Bates SM, Ginsberg JS. Treatment of deep-vein thrombosis. N Engl J Med 2004; 351:268-277.
30. Pavcnik D, Machan L, Uchida B, et al. Percutaneous prosthetic venous valves: current state and possible applications. Tech Vasc Interv Radiol 2003; 6:137-142.
31. Vedantham S, Vesely TM, Sicard GA, et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004; 15:565-574.
32. Chang R, Cannon RO III, Chen CC, et al. Daily catheter-directed single dosing of t-PA in treatment of acute deep venous thrombosis of the lower extremity. J Vasc Interv Radiol 2001; 12:247-252.